SCHEMBL13776901

SCHEMBL13776901

Cc1cc(C)c(C)c(-c2ccc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)cc2)c1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 12/20 0.56
▸ KMT2A Q03164 12/20 0.56
▸ MAPT P10636 9/20 0.56
▸ ALDH1A1 P00352 9/20 0.56
▸ HPGD P15428 8/20 0.56
▸ NTSR1 P30989 1/20 0.56
▸ KDM4E B2RXH2 6/20 0.54
▸ POLB P06746 1/20 0.54
▸ PKM P14618 1/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ BRD4 O60885 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.49
▸ RXFP1 Q9HBX9 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ LMNA P02545 2/20 0.49
▸ GLA P06280 1/20 0.49
▸ L3MBTL1 Q9Y468 3/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ ADORA2A P29274 2/20 0.49
▸ ADORA1 P30542 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13776864 1.00 MEN1 (0.56) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL13776852 0.91 MEN1 (0.56) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL13700778 0.91 L3MBTL1 (0.55) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL13776848 0.90 MEN1 (0.51) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL13776845 0.87 MEN1 (0.59) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL13776839 0.86 MEN1 (0.54) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL13776841 0.84 MEN1 (0.59) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22212998 0.83 MEN1 (0.70) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL13700782 0.82 L3MBTL1 (0.57) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22212993 0.81 MEN1 (0.68) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191426-A2 ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT PIONEER CORPORATION (JP) 2009-07-30 — — US disclosed
US-20080145699-A1 Organic Compound, Charge-Transporting Material, and Organic Electroluminescent Element PIONEER CORPORATION (JP) 2008-06-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191426-A2 ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT SLC39A3, SLCO2A1, SLC39A11 MEN1 2193/4885KMT2A 1792/4885MAPT 1991/4885
US-20080145699-A1 Organic Compound, Charge-Transporting Material, and Organic Electroluminescent Element SLC39A3, SLCO2A1, SLC39A11 MEN1 2193/4885KMT2A 1792/4885MAPT 1991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback